Chimin(SH:603222) 智通财经网·2025-09-11 12:04Core Viewpoint - Jimin Health (603222.SH) has issued a risk warning due to significant stock price fluctuations and a notable divergence from its operational performance, indicating potential risks for investors [1] Stock Performance - The company's stock closed at a daily limit increase, with a turnover rate of 16.96% - From September 8 to 11, 2025, the cumulative increase in closing price reached 33.78% - Over the past 30 trading days, the stock's price deviation from the Shanghai A-share index has accumulated to 94.72% [1] Financial Performance - For the fiscal year 2024, the net profit attributable to the parent company was -59.71 million yuan - In the first half of 2025, the net profit attributable to the parent company was -52.70 million yuan - The company is currently in a loss position, and its stock price trend is significantly deviating from its operational performance [1]